Price Alert: Shares of Enlivex (ENLV) Trade 2.95% Higher at Midday May 13

Equities Staff  |

Today Enlivex Therapeutics Ltd (NASDAQ: ENLV) is trading 2.95% higher.

The latest price, as of 11:49:13 est, was $4.19. Enlivex has risen $0.12 so far today.

59,985 shares have been traded today.

As of the previous close, Enlivex has a YTD change of 34.88%. The company is set to release earnings on 2022-05-27.

For technical charts, analysis, and more on Enlivex visit the company profile.

About Enlivex Therapeutics Ltd

Enlivex is a clinical stage immunotherapy company developing AllocetraTM, a universal, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. Resetting non-homeostatic macrophages into their homeostatic state is critical for immune system rebalancing and resolution of life-threatening conditions.

To get more information on Enlivex Therapeutics Ltd and to follow the company's latest updates, you can visit the company's profile page here: Enlivex Therapeutics Ltd's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast
Under Armour CEO Patrik Frisk To Step Down in Surprise Announcement
Target Hits 52-Week Low After Missing Badly on First Quarter Earnings
DLocal Posts Record Q1, Fifth Consecutive 100%+ Revenue Growth Quarter
Another Crypto Winter Wipes Out Billions in Market Value
Inflation + Recession = Recipe for Volatility
Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold
The Best Laid Plans of Mice and Men — Part I

Market Movers

Sponsored Financial Content